Cornea/External Disease News

Aldeyra Therapeutics has enrolled the first patient in a phase 3 clinical trial designed to allow possible resubmission of the new drug application of topical 0.25% reproxalap for dry eye disease, according to a company press release.

More than half of patients with type 2 diabetic nephropathy had dry eye disease, which was independently associated with older age, high HbA1C and reduced glomerular filtration rate, according to research conducted in Vietnam.

Cyclosporine 0.05% outperformed artificial tears in improving tear film quality and stability in the treatment of dry eye disease after cataract surgery, according to a study published in Annals of Medicine & Surgery.

Lumibird Medical announced the launch of C.DIAG, a diagnostic aid platform that uses AI algorithms to help health care providers diagnose patients with dry eye disease.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, John D. Sheppard, MD, MMSc, FACS, discusses a post hoc analysis investigating Miebo for the treatment of dry eye disease at different levels of severity.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Neda Gioia, OD, CNS, FOWNS, discusses two studies investigating a novel oral supplement from Bausch + Lomb for patients with dry eye disease.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Eric D. Donnenfeld, MD, discusses research that investigated Blink Triple Care artificial tears for the treatment of dry eye disease.

Using a computer for 30 minutes significantly increased the frequency and severity of dry eye symptoms in individuals who had and had not undergone LASIK, according to a study published in Ophthalmic and Physiological Optics.

Ocular surface disease must be addressed before cataract surgery to ensure patient satisfaction and good surgical outcomes, according to a presentation at Real World Ophthalmology.

Subject dosing is complete in a phase 1/2 clinical trial of an allogeneic cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press release.